| 000 | 01098 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250511220309.0 | ||
| 264 | 0 | _c19910612 | |
| 008 | 199106s 0 0 eng d | ||
| 022 | _a1042-9611 | ||
| 024 | 7 |
_a10.1177/106002809102500307 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBaciewicz, A M | |
| 245 | 0 | 0 |
_aConversion of intravenous ranitidine to oral therapy. _h[electronic resource] |
| 260 |
_bDICP : the annals of pharmacotherapy _cMar 1991 |
||
| 300 |
_a251-2 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aContraindications |
| 650 | 0 | 4 | _aCosts and Cost Analysis |
| 650 | 0 | 4 | _aDrug Utilization |
| 650 | 0 | 4 | _aHospitals, University |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 |
_aRanitidine _xadministration & dosage |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aTime Factors |
| 773 | 0 |
_tDICP : the annals of pharmacotherapy _gvol. 25 _gno. 3 _gp. 251-2 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1177/106002809102500307 _zAvailable from publisher's website |
| 999 |
_c2034812 _d2034812 |
||